Randomized trial explores mitochondrial metabolism's role in chemotherapy sensitivity in colorectal cancer, suggesting a new therapeutic approach.
Key Points
The central aim is to understand how mitochondrial metabolism influences the sensitivity of colorectal cancer cells to chemotherapy, specifically 5-fluorouracil.
Examined mitochondrial changes in colorectal cancer models after 5-fluorouracil treatment.
Targeted mitochondrial function by inhibiting Complex I to evaluate effects on chemotherapy sensitivity.
Analyzed patient data for oxidative metabolism signatures related to chemotherapy response.
5-fluorouracil increased mitochondrial biogenesis and function in surviving colorectal cancer cells.
Inhibiting Complex I significantly sensitized colorectal cancer cells to 5-fluorouracil, delaying tumor growth and improving survival in preclinical models.
Oxidative metabolism signatures were identified as potential predictors for responses to 5-fluorouracil-based chemotherapy.